Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 12,861 shares at $177.62 ($2.3M) on 2021-07-15, disclosed to the SEC on 2021-07-19.
Open-market sale of $2.3M NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $177.62 | 730 | $130K | 5.6% |
| 2 | $177.62 | 730 | $130K | 5.6% |
| 3 | $178.19 | 2,318 | $413K | 17.9% |
| 4 | $178.19 | 2,318 | $413K | 17.9% |
| 5 | $179.14 | 161 | $29K | 1.3% |
| 6 | $179.14 | 2,253 |
| $404K |
| 17.5% |
| 7 | $179.29 | 796 | $143K | 6.2% |
| 8 | $179.29 | 796 | $143K | 6.2% |
| 9 | $180.57 | 550 | $99K | 4.3% |
| 10 | $180.57 | 550 | $99K | 4.3% |
| 11 | $181.45 | 560 | $102K | 4.4% |
| 12 | $182.38 | 300 | $55K | 2.4% |
| 13 | $183.81 | 399 | $73K | 3.2% |
| 14 | $183.81 | 399 | $73K | 3.2% |
| 15 | $184.27 | 1 | $184 | 0.0% |
| Total | $179.23 avg | 12,861 | $2.3M | 100% |
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |